Request for Covid-19 Impact Assessment of this Report
Bayer (DE)
Novacap (FR)
Abbott
Pfizer Inc
Geri-Care Pharmaceuticals
Perrigo Company
Kopran Ltd.
Merck Sharp & Dohme Corp.
Sun Pharmaceutical Industries Ltd
GlaxoSmithKline
Reddy Pharmaceuticals Ltd
Johnson & Johnson
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Aspirin
Ibuprofen
Naproxen
Nabumetone
Others
Split by applications, this report focuses on sales, market share and growth rate of Non-steroidal Anti-inflammatory Drugs (NSAID) in each application, can be divided into
Back pain treatment
Osteoarthritis treatment
Other disease treatment
United States Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Market Report 2021
1 Non-steroidal Anti-inflammatory Drugs (NSAID) Overview
1.1 Product Overview and Scope of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2 Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.2.1 Aspirin
1.2.2 Ibuprofen
1.2.3 Naproxen
1.2.4 Nabumetone
1.2.5 Others
1.3 Applications of Non-steroidal Anti-inflammatory Drugs (NSAID)
1.3.1 Back pain treatment
1.3.2 Osteoarthritis treatment
1.3.3 Other disease treatment
1.4 USA Market Size (Value and Volume) of Non-steroidal Anti-inflammatory Drugs (NSAID) (2011-2021)
1.4.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Price (2011-2021)
1.4.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)
1.4.3 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Competition by Manufacturers
2.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Share by Manufactures (2015 and 2016)
3 USA Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume and Value) by Type
3.1 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2011-2021)
3.2 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2011-2021)
4 USA Non-steroidal Anti-inflammatory Drugs (NSAID) (Volume) by Application
5 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Manufacturers Analysis
5.1 Bayer (DE)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Product Type and Technology
5.1.2.1 Aspirin
5.1.2.2 Ibuprofen
5.1.3 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Bayer (DE) (2015 and 2016)
5.2 Novacap (FR)
5.2.1 Company Basic Information,Manufacturing Base and Competitors
5.2.2 Pharmaceuticals Product Type and Technology
5.2.2.1 Aspirin
5.2.2.2 Ibuprofen
5.2.3 Pharmaceuticals Sales, Revenue, Price of Novacap (FR) (2015 and 2016)
5.3 Abbott
5.3.1 Company Basic Information,Manufacturing Base and Competitors
5.3.2 Abbott Product Type and Technology
5.3.2.1 Aspirin
5.3.2.2 Ibuprofen
5.3.3 Abbott Sales, Revenue, Price of Abbott (2015 and 2016)
5.4 Pfizer Inc
5.4.1 Company Basic Information,Manufacturing Base and Competitors
5.4.2 Sun Pharmaceutical Industries Ltd Product Type and Technology
5.4.2.1 Aspirin
5.4.2.2 Ibuprofen
5.4.3 Pfizer Inc Sales, Revenue, Price of Pfizer Inc (2015 and 2016)
5.5 Geri-Care Pharmaceuticals
5.5.1 Company Basic Information,Manufacturing Base and Competitors
5.5.2 Geri-Care Pharmaceuticals Product Type and Technology
5.5.2.1 Aspirin
5.5.2.2 Ibuprofen
5.5.3 Geri-Care Pharmaceuticals Sales, Revenue, Price of Geri-Care Pharmaceuticals (2015 and 2016)
5.6 Perrigo Company
5.6.1 Company Basic Information,Manufacturing Base and Competitors
5.6.2 Perrigo Company Product Type and Technology
5.6.2.1 Aspirin
5.6.2.2 Ibuprofen
5.6.3 Perrigo Company Sales, Revenue, Price of Perrigo Company (2015 and 2016)
5.7 Kopran Ltd.
5.7.1 Company Basic Information,Manufacturing Base and Competitors
5.7.2 Kopran Ltd. Product Type and Technology
5.7.2.1 Aspirin
5.7.2.2 Ibuprofen
5.7.3 Kopran Ltd. Sales, Revenue, Price of Kopran Ltd. (2015 and 2016)
5.8 Merck Sharp & Dohme Corp.
5.8.1 Company Basic Information,Manufacturing Base and Competitors
5.8.2 Merck Sharp & Dohme Corp. Product Type and Technology
5.8.2.1 Aspirin
5.8.2.2 Ibuprofen
5.8.3 Merck Sharp & Dohme Corp. Sales, Revenue, Price of Merck Sharp & Dohme Corp. (2015 and 2016)
5.9 Sun Pharmaceutical Industries Ltd
5.9.1 Company Basic Information,Manufacturing Base and Competitors
5.9.2 Sun Pharmaceutical Industries Ltd Product Type and Technology
5.9.2.1 Aspirin
5.9.2.2 Ibuprofen
5.9.3 Sun Pharmaceutical Industries Ltd Sales, Revenue, Price of Sun Pharmaceutical Industries Ltd (2015 and 2016)
5.10 GlaxoSmithKline
5.10.1 Company Basic Information,Manufacturing Base and Competitors
5.10.2 GlaxoSmithKline Product Type and Technology
5.10.2.1 Aspirin
5.10.2.2 Ibuprofen
5.10.3 GlaxoSmithKline Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
5.11 Reddy Pharmaceuticals Ltd
5.12 Johnson & Johnson
6 Non-steroidal Anti-inflammatory Drugs (NSAID) Technology and Development Trend
6.1 Non-steroidal Anti-inflammatory Drugs (NSAID) Technology Analysis
6.2 Non-steroidal Anti-inflammatory Drugs (NSAID) Technology Development Trend
7 Research Findings and Conclusion
Figure Picture of Non-steroidal Anti-inflammatory Drugs (NSAID)
Table Classification of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure USA Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type in 2015
Figure Aspirin Picture
Figure Ibuprofen Picture
Figure Naproxen Picture
Figure Nabumetone Picture
Figure Others Picture
Table Applications of Non-steroidal Anti-inflammatory Drugs (NSAID)
Figure USA Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application in 2015
Figure Back pain treatment Examples
Figure Osteoarthritis treatment Examples
Figure Other disease treatment Examples
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue and Price (2011-2021)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Growth Rate (2011-2021)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Growth Rate (2011-2021)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales of Key Manufacturers (2015 and 2016)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Figure 2016 Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Manufacturers
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue by Manufacturers (2015 and 2016)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table 2016 USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Manufacturers
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Type (2011-2021)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Type (2011-2021)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2011-2021)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Type (2011-2021)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue and Market Share by Type (2011-2021)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Share by Type (2011-2021)
Figure Revenue Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Type (2011-2021)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Revenue Growth Rate by Type (2011-2021)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales and Market Share by Application (2011-2021)
Table USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Share by Application (2011-2021)
Figure Sales Market Share of Non-steroidal Anti-inflammatory Drugs (NSAID) by Application (2011-2021)
Figure USA Non-steroidal Anti-inflammatory Drugs (NSAID) Sales Growth Rate by Application (2011-2021)
Table Bayer (DE) Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Bayer (DE) (2015 and 2016)
Table Novacap (FR) Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Novacap (FR) (2015 and 2016)
Table Abbott Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Abbott (2015 and 2016)
Table Pfizer Inc Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Pfizer Inc (2015 and 2016)
Table Geri-Care Pharmaceuticals Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Geri-Care Pharmaceuticals (2015 and 2016)
Table Perrigo Company Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Perrigo Company (2015 and 2016)
Table Kopran Ltd. Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Kopran Ltd. (2015 and 2016)
Table Merck Sharp & Dohme Corp. Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Merck Sharp & Dohme Corp. (2015 and 2016)
Table Sun Pharmaceutical Industries Ltd Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Sun Pharmaceutical Industries Ltd (2015 and 2016)
Table GlaxoSmithKline Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)
Table Reddy Pharmaceuticals Ltd Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Reddy Pharmaceuticals Ltd (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Non-steroidal Anti-inflammatory Drugs (NSAID) Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...